MDI Biological Laboratory
MDI Science Café

MDI Science Cafe: Art Meets Science

  • August 26, 2024
  • 5:00 - 6:00 pm
  • Hybrid: Maren Auditorium and Zoom

“To develop a complete mind: Study the science of art; study the art of science. Learn how to see. Realize that everything connects to everything else.” - Leonardo da Vinci

MDI Bio Lab has been a center of scientific excellence on the coast of Maine for over 125 years. Our approach is to seek answers within the natural world, paired with a deep understanding of the scientific process. Our scientists work collaboratively to understand the secrets of how nature works and to apply that understanding to improve the human condition. Our work is focused on discovering novel cellular and molecular mechanisms of disease and translating our basic research discoveries into potential therapies.
“Making the Secrets of Nature Visible: Science and Art,” the 2024 theme of our Art Meets Science program, is centered on the belief that both art and science offer legitimate ways to better comprehend our world. Discerning the differences and similarities between the artistic process and the scientific method helps refine our research strategies and better communicate our work. “Science and Art” beautifully enhances the MDI Bio Lab’s research and education activities, helping us to develop a complete mind and explore how art can communicate and catalyze science.
As a community, we will study the science of art; study the art of science. Learn how to see. Realize that everything connects to everything else.
Dr. Hermann Haller was named president of MDIBL in 2018 after serving as a faculty member and visiting scientist for more than 20 years, researching acute and chronic kidney damage. Currently, the Haller Lab uses stem cells to grow new renal tissue in an effort to unlock the secrets to growing replacement kidneys. In addition to his position at MDIBL, Haller is a professor and former chairman of the Division of Nephrology at the Hannover Medical School in Germany and a skilled art historian. He has published more than 700 peer-reviewed articles, holds six worldwide patents and founded four biotech companies. Dr. Haller serves on numerous advisory boards, including those of Bayer, Boehringer Ingelheim, Genzyme and Novo Nordisk.
MDI Science Café Series brought to you by Cross Insurance
Cross Insurance Logo